GlassScriptPhysician profile
Gaurav Kumar Sharma
NPI 1831570720
$5,738.32
in general payments reported to CMS, 2019-2025
27 companies · $127 in 2025
The $127 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $654 · 2020: $226 · 2021: $421 · 2022: $1,202 · 2023: $1,181 · 2024: $1,927 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,051 · Travel and Lodging: $737 · Education: $446.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,050.95 |
| Travel and Lodging | $737.35 |
| Education | $446.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,291.11 | 2021-2024 | Perclose Proglide, Supera, Xience Skypoint |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $580.65 | 2019-2024 | Lifevest |
| Novartis Pharmaceuticals Corporation | $575.69 | 2019-2024 | |
| Abiomed | $392.77 | 2022-2025 | Impella |
| Medtronic, INC. | $378.38 | 2021-2024 | Onyx Frontier, Hawkone, In.Pact Admiral |
| Cardiovascular Systems INC. | $313.19 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $258.31 | 2021-2023 | Verquvo |
| Penumbra, INC. | $239.05 | 2024-2025 | Indigo System |
| Edwards Lifesciences Corporation | $196.53 | 2024 | Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $184.25 | 2022-2023 | Ekosonic |
| Shockwave Medical, INC | $175.49 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $152.21 | 2019-2023 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $140.80 | 2021-2023 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $137.77 | 2019-2025 | Camzyos |
| Janssen Pharmaceuticals, INC | $122.36 | 2022-2023 | Xarelto |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $113.45 | 2021-2023 | Brilinta |
| Pfizer INC. | $96.53 | 2019-2022 | |
| Lantheus Medical Imaging, INC. | $71.37 | 2019-2023 | Definity |
| Itamar Medical INC | $61.89 | 2023 | Watchpatone |
| Medtronic Vascular, INC. | $60.84 | 2019-2020 | |
| Novo Nordisk INC | $42.48 | 2023-2024 | Ozempic, Rybelsus, Wegovy |
| Actelion Pharmaceuticals US, INC. | $38.58 | 2023 | Uptravi, Opsumit |
| Astellas Pharma US INC | $35.94 | 2019-2021 | |
| Kestra Medical Technology Services, INC. | $23.85 | 2024 | Assure Wcd |
| Cook Medical LLC | $22.18 | 2024 | Zilver Ptx |
| Scpharmaceuticals INC. | $19.52 | 2023 | |
| Esperion Therapeutics, INC. | $13.13 | 2024 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gaurav Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.